Oppenheimer Asset Management Inc. increased its holdings in shares of Balchem Corporation (NASDAQ:BCPC) by 2.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,133 shares of the basic materials company’s stock after purchasing an additional 118 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Balchem Corporation were worth $400,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in BCPC. Victory Capital Management Inc. boosted its stake in Balchem Corporation by 17.6% during the second quarter. Victory Capital Management Inc. now owns 2,130 shares of the basic materials company’s stock valued at $166,000 after buying an additional 319 shares during the last quarter. Sei Investments Co. boosted its stake in Balchem Corporation by 117.9% during the second quarter. Sei Investments Co. now owns 2,465 shares of the basic materials company’s stock valued at $191,000 after buying an additional 1,334 shares during the last quarter. Turner Investments LLC boosted its stake in Balchem Corporation by 25.0% during the second quarter. Turner Investments LLC now owns 2,500 shares of the basic materials company’s stock valued at $194,000 after buying an additional 500 shares during the last quarter. Capital Analysts LLC bought a new position in Balchem Corporation during the second quarter valued at approximately $197,000. Finally, American Capital Management Inc. bought a new position in Balchem Corporation during the second quarter valued at approximately $218,000. Hedge funds and other institutional investors own 84.22% of the company’s stock.

Separately, BidaskClub lowered Balchem Corporation from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st.

Balchem Corporation (NASDAQ:BCPC) opened at 76.66 on Friday. Balchem Corporation has a 52 week low of $66.20 and a 52 week high of $89.50. The company’s 50-day moving average price is $75.27 and its 200-day moving average price is $79.15. The company has a market capitalization of $2.45 billion, a price-to-earnings ratio of 39.72 and a beta of 1.10.

Balchem Corporation (NASDAQ:BCPC) last posted its quarterly earnings data on Friday, August 4th. The basic materials company reported $0.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.01. Balchem Corporation had a return on equity of 14.99% and a net margin of 10.99%. The company had revenue of $147.08 million during the quarter. Equities analysts forecast that Balchem Corporation will post $2.47 earnings per share for the current fiscal year.

WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/17/balchem-corporation-bcpc-shares-bought-by-oppenheimer-asset-management-inc.html.

Balchem Corporation Profile

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Corporation (NASDAQ:BCPC).

Institutional Ownership by Quarter for Balchem Corporation (NASDAQ:BCPC)

Receive News & Stock Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related stocks with our FREE daily email newsletter.